Northwestern Mutual Wealth Management CO Viking Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 1,580 shares of VKTX stock, worth $44,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,580
Previous 28
5542.86%
Holding current value
$44,145
Previous $1,000
6200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VKTX
# of Institutions
467Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$284 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$168 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$138 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$72.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$60.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.14B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...